Clinical Trial Update: Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM) [NA]

View source ↗

Summary

A clinical trial evaluating intravitreal quantum dots for advanced Retinitis Pigmentosa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Intravitreal Quantum Dots

Snippet

Sponsor: 2C Tech Corp | Conditions: Retinitis Pigmentosa | NA | Status: WITHDRAWN